Results for tag: "Chronic Venous Insufficiency Drug"

Chronic Venous Insufficiency (CVI) is a condition in which the veins of the legs are unable to adequately return blood to the heart. It is a common cardiovascular disorder, and is often treated with drugs. These drugs are used to improve blood flow, reduce swelling, and reduce the risk of complications such as ulcers and blood clots. Commonly used drugs include diuretics, anticoagulants, and vasodilators. The CVI drug market is a rapidly growing segment of the cardiovascular drug market. It is driven by an aging population, increasing prevalence of CVI, and the development of new drugs. The market is expected to continue to grow in the coming years, as new treatments are developed and more patients are diagnosed. Some of the major companies in the CVI drug market include Pfizer, Merck, Sanofi, Novartis, and Bayer. Show Less Read more